T. G. Pereira

Breakthrough attacks in patients with hereditary angioedema receiving long-term prophylaxis are responsive to icatibant: findings from the Icatibant Outcome Survey

W. Aberer, B. Goichot, S. Kivity, 2017, Allergy, Asthma & Clinical Immunology.